Rebecca Taub - Pres., R&D, and CMO, Director at Madrigal Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Pres., R&D, and CMO, Director
Stock Symbol
MDGL on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Rebecca Taub - trading volume in the past year for Madrigal Pharmaceuticals, Inc.

Holdings reported by Rebecca Taub for Madrigal Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 656K $220M $335.24 Jan 24, 2025 By SQN LLC
Common Stock 457K $153M $335.24 Jan 24, 2025 Direct
Stock Option (Right to Buy) 76.6K Apr 8, 2024 Direct Common Stock

Transactions reported by Rebecca Taub for Madrigal Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.